Your browser doesn't support javascript.
loading
Slovenian Version of the Drug-Induced Extrapyramidal Symptoms Scale: Evaluation of Interrater and Test-Retest Reliability.
Senica, Nina; Aleksic, Branko; Inada, Toshiya; Iljes, Anja Plemenitas; Zamuda, Tilen; Kumperscak, Hojka Gregoric.
Affiliation
  • Senica N; From the Department for Child and Adolescent Psychiatry, University Medical Centre Maribor, Maribor, Slovenia.
  • Aleksic B; Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Inada T; Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Iljes AP; Department for Psychiatry, University Medical Centre Maribor, Maribor, Slovenia.
  • Zamuda T; Department for Psychiatry, University Medical Centre Maribor, Maribor, Slovenia.
  • Kumperscak HG; From the Department for Child and Adolescent Psychiatry, University Medical Centre Maribor, Maribor, Slovenia.
J Clin Psychopharmacol ; 43(4): 361-364, 2023.
Article in En | MEDLINE | ID: mdl-37104664
ABSTRACT

AIM:

The Drug-Induced Extrapyramidal Symptom Scale (DIEPSS) is a multidimensional rating scale for the assessment of drug-induced extrapyramidal symptoms (EPS), developed in 1994. It is suitable for evaluating EPS considering the degree of influence EPS has on daily activities and the subjective distress that it causes.

METHOD:

This study to evaluate the interrater and test-retest reliability of the DIEPSS Slovenian version conducted at the University Medical Center Maribor in Slovenia in November 2018.

RESULTS:

Six raters performed the interrater assessment of 135 DIEPSS video clips with recordings of patients with EPS. A second assessment was then performed by 2 raters to evaluate the test-retest reliability, which was high (interclass correlation coefficients from 0.743 to 0.936).

CONCLUSIONS:

The results for the Slovenian language version of the DIEPSS show high interrater and test-retest reliability, with high concordance rates for all evaluated items (interclass correlation coefficient > 0.8).
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Basal Ganglia Diseases Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Clin Psychopharmacol Year: 2023 Document type: Article Affiliation country: Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Basal Ganglia Diseases Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Clin Psychopharmacol Year: 2023 Document type: Article Affiliation country: Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA